Key stats
About Horizon Kinetics Medical ETF
Home page
Inception date
Jan 30, 2023
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
Horizon Kinetics Asset Management LLC
Distributor
Foreside Fund Services LLC
ISIN
US53656G5633
MEDX aims for long-term capital growth through investments in global companies engaged in the broad healthcare sector. The portfolio may include companies of any market capitalization. Eligible securities must have at least 50% of their company revenue in medical research, pharmaceuticals, and medical technology. Such companies may include surgical & medical instrument manufacturers and biotech names. The portfolio emphasizes companies whose activities specifically involve cancer research, treatment, and pharmaceutical development. Selection and weighting are based on the advisers evaluation of a companys fundamentals, industrial position, and capital investments. During temporary periods, the fund may invest up to 100% of its assets in US short-term debt securities and money market instruments. The fund may invest up to 20% in convertibles and non-convertible high-yield bonds. The fund is actively managed and the adviser has full discretion in adjusting the portfolio.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks90.20%
Health Technology90.20%
Bonds, Cash & Other9.80%
Cash9.80%
Stock breakdown by region
North America73.71%
Europe26.29%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
MEDX last dividends amounted to 0.46 USD. The year before, the issuer paid 0.05 USD in dividends, which shows a 90.09% increase.
MEDX assets under management is 17.17 M USD. It's risen 0.61% over the last month.
MEDX fund flows account for 683.94 K USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, MEDX pays dividends to its holders with the dividend yield of 1.57%. The last dividend (Dec 26, 2024) amounted to 0.50 USD. The dividends are paid annually.
MEDX shares are issued by Horizon Kinetics Holding Corp. under the brand Horizon. The ETF was launched on Jan 30, 2023, and its management style is Active.
MEDX expense ratio is 0.85% meaning you'd have to pay 0.85% of your investment to help manage the fund.
MEDX follows the No Underlying Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
MEDX invests in stocks.
MEDX price has risen by 1.44% over the last month, and its yearly performance shows a −4.67% decrease. See more dynamics on MEDX price chart.
NAV returns, another gauge of an ETF dynamics, showed a 9.25% increase in three-month performance and has decreased by −2.91% in a year.
NAV returns, another gauge of an ETF dynamics, showed a 9.25% increase in three-month performance and has decreased by −2.91% in a year.
MEDX trades at a premium (0.05%) meaning the ETF is trading at a higher price than the calculated NAV.